Nursing Elites

1. A client who is bleeding after a vaginal delivery receives a prescription for methylergonovine (Methergine) 0.4 mg IM every 2 hours, not to exceed 5 doses. The medication is available in ampules containing 0.2 mg/ml. What is the maximum dosage in mg that the nurse should administer to this client?

• A. Encourage oral fluids as tolerated
• B. Decrease oral intake to 200 ml
• C. Allow the client to have exactly 400 ml oral intake
• D. Limit oral intake to 900 to 1,000 ml

Correct answer: D

Rationale: The maximum dosage the nurse should administer is 2 mg. This is calculated based on the prescription of 0.4 mg IM every 2 hours, not to exceed 5 doses. Since the medication is available in ampules containing 0.2 mg/ml, the nurse should administer 2 ml (0.2 mg/ml x 10 ml) for each dose, not exceeding 5 doses. Therefore, the nurse should limit the client's oral intake to 900 to 1,000 ml, to avoid exceeding the maximum dosage of 2 mg.

2. The nurse assesses a client who is receiving an infusion of 5% dextrose in water with 20 mEq of potassium chloride. The client has oliguria and a serum potassium level of 6.5 mEq/L. What action should the nurse implement first?

• A. Notify the healthcare provider of the laboratory results
• B. Decrease the rate of the IV infusion
• C. Stop the infusion
• D. Administer sodium polystyrene sulfonate (Kayexalate)

Correct answer: C

Rationale: The correct action for the nurse to implement first is to stop the infusion. Stopping the infusion is crucial to prevent further potassium from being administered, which can exacerbate the client's hyperkalemia. Notifying the healthcare provider of the laboratory results (Choice A) can be done after taking immediate action to stop the infusion. Decreasing the rate of the IV infusion (Choice B) may not be sufficient to address the high potassium level quickly. Administering sodium polystyrene sulfonate (Kayexalate) (Choice D) is not the initial action for managing hyperkalemia; stopping the potassium infusion takes precedence.

3. A client who had an intraosseous (IO) cannula placed by the healthcare provider for emergent fluid resuscitation is complaining of severe pain and numbness below the IO site. The skin around the site is pale and edematous. What action should the nurse take first?

• A. Discontinue the IO infusion
• B. Administer an analgesic via the IO site
• C. Elevate the extremity with the IO site
• D. Notify the healthcare provider

Correct answer: A

Rationale: In this scenario, the client's symptoms of severe pain, numbness, pale skin, and edema below the IO site raise concerns for complications like compartment syndrome or extravasation. The priority action for the nurse is to discontinue the IO infusion to prevent further harm to the client. Administering an analgesic via the IO site or elevating the extremity with the IO site may delay addressing the potential serious complications. While notifying the healthcare provider is important, the immediate action to ensure client safety is to stop the infusion.

4. The client diagnosed with a right fractured femur has skeletal traction applied to the right femur. Which interventions should the nurse implement?

• A. Perform passive range of motion to the right leg
• B. Remove skeletal weights every shift to assess right leg
• C. Turn frequently from prone to supine positions
• D. Maintain skeletal pin sites and assess for signs of infection

Correct answer: D

Rationale: Maintaining skeletal pin sites and assessing for infection are critical in skeletal traction care.

5. What assessment technique should the nurse use to monitor a client for a common untoward effect of phenytoin (Dilantin)?

• A. Bladder palpation
• B. Inspection of the mouth
• C. Blood glucose monitoring
• D. Auscultation of breath sounds

Correct answer: B

Rationale: The correct answer is B: Inspection of the mouth. This assessment technique is crucial for monitoring gingival hyperplasia, a common side effect of phenytoin. Bladder palpation (choice A) is not relevant to monitoring for phenytoin's side effects. Blood glucose monitoring (choice C) is important for clients with diabetes but is not specifically related to phenytoin. Auscultation of breath sounds (choice D) is more relevant for assessing respiratory conditions, not side effects of phenytoin.

Similar Questions